Topical phenylephrine for the treatment of middle ear effusion

Insights

Phenylephrine hydrochloride nasal spray and nose drops did not hasten middle ear effusion resolution in children. The study found similar cure rates between medication and placebo groups, suggesting limited efficacy for topical decongestants in this condition.

Area of Science:

  • Pediatrics
  • Otolaryngology
  • Clinical Pharmacology

Background:

  • Middle ear effusion (MEE) is a common complication following acute otitis media in children.
  • Persistent MEE can lead to hearing impairment and speech delays.
  • Topical decongestants are sometimes considered for MEE treatment, but their efficacy is not well-established.

Purpose of the Study:

  • To evaluate the efficacy of phenylephrine hydrochloride nasal drops or spray in accelerating the resolution of MEE in children.
  • To compare clinical and tympanometric cure rates between phenylephrine hydrochloride and placebo treatments.

Main Methods:

  • A randomized, controlled clinical trial was conducted with 152 children experiencing persistent MEE.
  • Participants received either phenylephrine hydrochloride nasal spray/drops or a placebo.
  • Outcomes were assessed over a four-week period, monitoring clinical signs and tympanometry.

Main Results:

  • A significant number of participants (30% and 18%) dropped out or were excluded due to intolerance or intercurrent conditions.
  • Among children who completed the study, no significant difference in clinical or tympanometric cure rates was observed between the phenylephrine hydrochloride and placebo groups.
  • Administration of nasal drops and spray proved difficult for many pediatric patients.

Conclusions:

  • Phenylephrine hydrochloride nasal preparations demonstrated no significant clinical efficacy in hastening the resolution of middle ear effusion in children.
  • Practical challenges in administration and lack of proven benefit suggest a limited role for topical decongestants in managing pediatric MEE.
  • Further research may be needed to explore alternative or adjunctive treatments for persistent middle ear effusion.

Related Concept Videos

Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations: